Genomic Health to Launch Colon Cancer Test This Quarter | GenomeWeb

SAN FRANCISCO (GenomeWeb News) – Genomic Health will launch its colon cancer test this quarter and will hire additional sales people in connection with the introduction, President and CEO Kim Popovits said Monday at the JP Morgan Healthcare Conference, held here this week.

The pharmacogenomics firm currently has 80 sales people and expects to add another 10 this quarter. Popovits said that its entire sales force would sell both the Oncotype Dx for breast cancer and the new assay for colon cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.